SIRT2 and infection: A similar inhibitory effect on HBV RNA accumulation and promoter activity was observed for FLS-359; in this study, the SIRT2 modulator was also shown to inhibit the establishment of cccDNA at a point after the virus had entered the cell, when the drug was present at the start of the infection [34].